These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36870734)

  • 1. Evaluation of the EUROIMMUN Aspergillus antigen immunoenzyme assay in serum and bronchoalveolar lavage fluid samples.
    Roiz-Mesones MP; Pintos-Fonseca AM; Ahedo-García N; Alegría-Puig CR
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Mar; 41(3):176-180. PubMed ID: 36870734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
    Musher B; Fredricks D; Leisenring W; Balajee SA; Smith C; Marr KA
    J Clin Microbiol; 2004 Dec; 42(12):5517-22. PubMed ID: 15583275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the JF5-Based Galactomannoprotein EIA Compared to the Lateral Flow Device and the Galactomannan EIA in Serum and Bronchoalveolar Lavage Fluid.
    Aerts R; Mercier T; Houben E; Schauwvlieghe A; Lagrou K; Maertens J
    J Clin Microbiol; 2022 Nov; 60(11):e0094822. PubMed ID: 36214562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Evaluation of the Performance of the IMMY
    White PL; Price JS; Posso R; Vale L; Backx M
    J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32967903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the sōna
    Jani K; McMillen T; Morjaria S; Babady NE
    J Clin Microbiol; 2021 Aug; 59(9):e0059821. PubMed ID: 34232067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.
    Francesconi A; Kasai M; Petraitiene R; Petraitis V; Kelaher AM; Schaufele R; Hope WW; Shea YR; Bacher J; Walsh TJ
    J Clin Microbiol; 2006 Jul; 44(7):2475-80. PubMed ID: 16825367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
    Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
    Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.
    Alhan O; Saba R; Akalin EH; Ener B; Ture Yuce Z; Deveci B; Guncu MM; Kahveci HN; Yilmaz AF; Odabasi Z
    Mycopathologia; 2023 Oct; 188(5):643-653. PubMed ID: 37273172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the diagnosis of invasive aspergillosis by the detection of Aspergillus in broncho-alveolar lavage fluid: Comparison of non-culture-based assays.
    Guegan H; Robert-Gangneux F; Camus C; Belaz S; Marchand T; Baldeyrou M; Gangneux JP
    J Infect; 2018 Feb; 76(2):196-205. PubMed ID: 29248586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis.
    Ghazanfari M; Yazdani Charati J; Davoodi L; Arastehfar A; Moazeni M; Abastabar M; Haghani I; Mayahi S; Hoenigl M; Pan W; Hedayati MT
    Mycoses; 2022 Oct; 65(10):960-968. PubMed ID: 35979737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies.
    Verweij PE; Latgé JP; Rijs AJ; Melchers WJ; De Pauw BE; Hoogkamp-Korstanje JA; Meis JF
    J Clin Microbiol; 1995 Dec; 33(12):3150-3. PubMed ID: 8586691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective Multicenter Evaluation of the VirClia Galactomannan Antigen Assay for the Diagnosis of Pulmonary Aspergillosis with Bronchoalveolar Lavage Fluid Samples from Patients with Hematological Disease.
    Buil JB; Huygens S; Dunbar A; Schauwvlieghe A; Reynders M; Langerak D; van Dijk K; Bruns A; Haas PJ; Postma DF; Biemond B; Delma FZ; de Kort E; Melchers WJG; Verweij PE; Rijnders B
    J Clin Microbiol; 2023 May; 61(5):e0004423. PubMed ID: 37097150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the Euroimmun Aspergillus Antigen ELISA for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid.
    Egger M; Penziner S; Dichtl K; Gornicec M; Kriegl L; Krause R; Khong E; Mehta S; Vargas M; Gianella S; Porrachia M; Jenks JD; Venkataraman I; Hoenigl M
    J Clin Microbiol; 2022 Apr; 60(4):e0021522. PubMed ID: 35350844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a Novel
    Dichtl K; Seybold U; Ormanns S; Horns H; Wagener J
    J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31018980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on invasive aspergillosis using galactomannan enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation.
    Ardi P; Daie-Ghazvini R; Hashemi SJ; Salehi MR; Bakhshi H; Rafat Z; Zareei M; Getso M; Basiri S; Sarwestani HK; Boroujeini ZB; Ahmadikia K
    Microb Pathog; 2020 Oct; 147():104382. PubMed ID: 32663605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
    Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
    Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis.
    Taghizadeh-Armaki M; Hedayati MT; Moqarabzadeh V; Ansari S; Mahdavi Omran S; Zarrinfar H; Saber S; Verweij PE; Denning DW; Seyedmousavi S
    J Med Microbiol; 2017 Jul; 66(7):898-904. PubMed ID: 28693685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of galactomannan in bronchoalveolar lavage of the intensive care unit patients at risk for invasive aspergillosis.
    Khodavaisy S; Hedayati MT; Alialy M; Habibi MR; Badali H
    Curr Med Mycol; 2015 Mar; 1(1):12-17. PubMed ID: 28680975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.